Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.41
- Piotroski Score 2.00
- Grade Buy
- Symbol (SCPH)
- Company scPharmaceuticals Inc.
- Price $3.36
- Changes Percentage (-2.89%)
- Change -$0.1
- Day Low $3.36
- Day High $3.53
- Year High $6.71
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/11/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.48
- Trailing P/E Ratio -2.53
- Forward P/E Ratio -2.53
- P/E Growth -2.53
- Net Income $-54,810,000
Income Statement
Quarterly
Annual
Latest News of SCPH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
scPharmaceuticals Inc., a pharmaceutical company, is analyzed for potential profitability by 2026. Industry analysts predict breakeven in 2025, followed by a profit of US$36m in 2026....
By Yahoo! Finance | 3 months ago
